Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan for Exercise Induced Pulmonary Hypertension in Systemic Sclerosis
NCT01051960Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Mar 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ambrisentan in pulmonary hypertension (PH), sponsored by University of California, Los Angeles. Started Mar 2009; status: completed.
02
Drugs
ambrisentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01051960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051960.